Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testing simultaneous hypotheses in pharmaceutical trials: a Bayesian approach

F Dominici1

  • 1Department of Biostatistics, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland 21205-2179, USA.

Journal of Biopharmaceutical Statistics
|May 23, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health disparities among older adults following tropical cyclone exposure in Florida.

Nature communications·2023
Same author

Assessing Adverse Health Effects of Long-Term Exposure to Low Levels of Ambient Air Pollution: Implementation of Causal Inference Methods.

Research report (Health Effects Institute)·2022
Same author

Air pollution and COVID-19 mortality in the United States: Strengths and limitations of an ecological regression analysis.

Science advances·2020
Same author

Evaluating the impact of long-term exposure to fine particulate matter on mortality among the elderly.

Science advances·2020
Same author

Assessing Adverse Health Effects of Long-Term Exposure to Low Levels of Ambient Air Pollution: Phase 1.

Research report (Health Effects Institute)·2020
Same author

Preservation of root cementum: a comparative evaluation of power-driven versus hand instruments.

International journal of dental hygiene·2016
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

The Bayes factor offers a more flexible tool than the likelihood ratio test for comparing new drugs against controls in pharmaceutical trials, especially with small sample sizes.

Area of Science:

  • Biostatistics
  • Pharmaceutical Sciences
  • Clinical Trial Design

Background:

  • Pharmaceutical trials often compare a new drug against a control (placebo or positive control).
  • Evaluating both efficacy (target effect) and safety (side effect) is crucial for drug approval.
  • Traditional statistical tests may not optimally handle simultaneous efficacy and toxicity assessments.

Purpose of the Study:

  • To compare the performance of the Bayes factor and the likelihood ratio test in pharmaceutical trials.
  • To assess the utility of these methods for jointly evaluating drug toxicity and efficacy.
  • To determine which method is more informative for simultaneous testing of target and side effects.

Main Methods:

  • A bivariate model was used, characterizing each treatment by a primary response (target effect) and a secondary response (side effect).

Related Experiment Videos

  • A Bayesian approach was employed, incorporating physician's prior inputs on target-toxicity relationships and maximum tolerated effects.
  • The Bayes factor and likelihood ratio test were applied to compare a new drug with a control.

    • Main Results:

    • The Bayes factor demonstrated greater flexibility and informativeness compared to the likelihood ratio test in simultaneous testing.
    • This advantage was particularly pronounced when the number of experimental subjects was small.
    • The study highlights the utility of the Bayes factor in complex pharmaceutical trial evaluations.

    Conclusions:

    • The Bayes factor is a more advantageous tool than the likelihood ratio test for simultaneous efficacy and safety testing in pharmaceutical trials.
    • Bayesian methods, incorporating prior information, enhance the evaluation of drug target-toxicity relationships.
    • The findings suggest the Bayes factor is particularly valuable in early-phase or small-sample pharmaceutical studies.